BioCentury
ARTICLE | Management Tracks

Mackison named CEO at Vico 

Plus Arvinas hires Northcott as CCO, Manion joins Aclaris and updates from AnHeart, Gracell, Find and more 

August 2, 2022 12:16 AM UTC

Neurology focused genetic medicine play Vico Therapeutics B.V. named Micah Mackison as CEO. Mackison was CBO and EVP of strategy and corporate development at Locanabio Inc., before which he was SVP of corporate development and strategy at Assembly Biosciences Inc. (NASDAQ:ASMB). Vico, whose series A round was led by LSP in 2020, is developing oligonucleotide-based RNA modulating therapies for CNS conditions. 

Protein degradation company Arvinas Inc. (NASDAQ:ARVN) hired John Northcott as chief commercial officer (CCO). Northcott was CCO of Nektar Therapeutics (NASDAQ:NKTR), Pharmacyclics Inc., and Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article